Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 6Phase 1 6Phase 1/2 5Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 60Unknown 8Active not recruiting 8Recruiting 6Terminated 4

Sponsor Class

OTHER 3OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1CNS 1

Conditions

Leukemia, Myeloid, Acute 2Recurrence 1Neuroblastoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Granulocyte Colony-Stimulating Factor × Clear all
NCT05586074 2026-04-28

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Sunshine Lake Pharma Co., Ltd.

Phase 3 Recruiting
324 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04685616 2026-03-30

RADAR

University College, London

Phase 3 Recruiting
1,042 enrolled
Lymphoid

Hodgkin Disease

NCT06520163 2025-12-04

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
99 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT05726110 2024-10-22

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Shanxi Bethune Hospital

Phase 3 Recruiting
50 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
99 enrolled
Plasma cell

Multiple Myeloma

NCT01704716 2020-10-23

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

St. Anna Kinderkrebsforschung

Phase 3 Recruiting
3,300 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡